-+ 0.00%
-+ 0.00%
-+ 0.00%

ADMA Biologics President and CEO Adam S. Grossman Reports Sale of $288,120 in Common Shares

PUBT·11/17/2026 02:02:35
Listen to the news
ADMA Biologics President and CEO Adam S. Grossman Reports Sale of $288,120 in Common Shares
  • ADMA Biologics President and CEO Adam S. Grossman sold 21,000 common shares at $13.72 each on November 16, 2026.
  • Grossman also exercised stock options to acquire 15,000 common shares at $5.4 each.
  • His direct beneficial ownership totaled 2,064,777 common shares following the transactions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ADMA Biologics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-26-044291), on November 16, 2026, and is solely responsible for the information contained therein.